<DOC>
<DOCNO>
EP-0017181
</DOCNO>
<TEXT>
<DATE>
19801015
</DATE>
<IPC-CLASSIFICATIONS>
A01N-43/90 C07D-233/00 C07D-233/54 C07D-487/04 C07D-403/00 C07D-233/64 C07D-487/00 C07C-45/51 C07C-47/14 C07D-403/06 C07C-47/02 C07C-45/00 
</IPC-CLASSIFICATIONS>
<TITLE>
process for the production of imidazobenzodiazepine derivatives, and intermediates for their production.
</TITLE>
<APPLICANT>
hoffmann la rochech<sep>f. hoffmann-la roche & co. aktiengesellschaft<sep>f. hoffmann-la roche &amp; co. aktiengesellschaftpostfach 32554002 baselch<sep>
</APPLICANT>
<INVENTOR>
field george francisus<sep>zally william jus<sep>field, george francis<sep>zally, william j.<sep>field, george francis33 mckinley avenuewest caldwell, n.j., 07006us<sep>zally, william j.24 milton streetcresskill, n.j. 07626us<sep>
</INVENTOR>
<ABSTRACT>
Imidazobenzodiazepines of the general formula wherein X and Y are hydrogen, halogen or trifluoromethyl, and pharmaceutically acceptable acid addition salts thereof are prepared according to a new method according to which one compound of the general formula wherein X and Y are above meaning by treating with a lower alkylamine ora hydrazine, or converted by acid or basic hydrolysis into a corresponding ver binding of the formula I, and desired in the absence of a pharmaceutically acceptable acid addition salt thereof.The compounds of formula I are known and exhibit useful sedative, anxiolytic, muscle relaxation and anticonvulsive effects.
</ABSTRACT>
</TEXT>
</DOC>
